Tim Kelly, PhD

"I am incredibly excited to help translate our innovations into reliable delivery of AAV gene therapy products to patients in need."

Tim Kelly, PhD

President, Manufacturing

Tim Kelly joined AskBio in March 2020 as President, Manufacturing with more than 20 years of experience in the development and manufacture of therapeutic proteins. He has overseen biopharmaceutical services for over 320 molecules at all stages of development and commercialization and supported numerous successful FDA and international regulatory inspections throughout his career.

Dr. Kelly most recently served as President and CEO of KBI Biopharma, a contract services organization headquartered in Durham, North Carolina that provides drug development and biomanufacturing services to pharmaceutical and biotechnology companies globally. He began his tenure at KBI in 2005, initially acting as Vice President of Biopharmaceutical Development where he led the establishment and growth of KBI’s analytical development, formulation development and cGMP laboratory services business. He subsequently served as Executive Vice President of Operations with responsibility for KBI’s development and manufacturing functions in North Carolina and Colorado. Prior to KBI, he directed the quality control function for Diosynth Biotechnology, where he supported clinical and commercial biopharmaceutical products. Dr. Kelly earned his PhD in molecular genetics and biochemistry from Georgia State University.